Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Show all queries
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT00147602
Registration number
NCT00147602
Ethics application status
Date submitted
6/09/2005
Date registered
7/09/2005
Date last updated
22/04/2015
Titles & IDs
Public title
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Query!
Scientific title
A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke
Query!
Secondary ID [1]
0
0
A2581138
Query!
Secondary ID [2]
0
0
0981-342
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
SPARCL
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cardiovascular Disease
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Time to occurrence of fatal or non-fatal stroke
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Secondary outcome [1]
0
0
Time to occurrence of an acute coronary event, consisting of cardiac death, nonfatal myocardial infarction, resuscitated cardiac arrest or unstable angina.
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Secondary outcome [2]
0
0
Time to occurrence of a cerebrovascular event, defined as fatal or nonfatal stroke or TIA.
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
Query!
Eligibility
Key inclusion criteria
* Previous stroke or TIA
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* coronary heart disease
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/11/1998
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,VIC,WA
Query!
Recruitment hospital [1]
0
0
Pfizer Investigational Site - East Gosford
Query!
Recruitment hospital [2]
0
0
Pfizer Investigational Site - Randwick, Sydney
Query!
Recruitment hospital [3]
0
0
Pfizer Investigational Site - Footscray
Query!
Recruitment hospital [4]
0
0
Pfizer Investigational Site - Heidelberg Heights
Query!
Recruitment hospital [5]
0
0
Pfizer Investigational Site - Parkville
Query!
Recruitment hospital [6]
0
0
Pfizer Investigational Site - Prahran
Query!
Recruitment hospital [7]
0
0
Pfizer Investigational Site - Perth
Query!
Recruitment postcode(s) [1]
0
0
2250 - East Gosford
Query!
Recruitment postcode(s) [2]
0
0
2031 - Randwick, Sydney
Query!
Recruitment postcode(s) [3]
0
0
3011 - Footscray
Query!
Recruitment postcode(s) [4]
0
0
3081 - Heidelberg Heights
Query!
Recruitment postcode(s) [5]
0
0
3050 - Parkville
Query!
Recruitment postcode(s) [6]
0
0
3181 - Prahran
Query!
Recruitment postcode(s) [7]
0
0
6000 - Perth
Query!
Recruitment outside Australia
Country [1]
0
0
Austria
Query!
State/province [1]
0
0
Graz
Query!
Country [2]
0
0
Austria
Query!
State/province [2]
0
0
Innsbruck
Query!
Country [3]
0
0
Austria
Query!
State/province [3]
0
0
Villach
Query!
Country [4]
0
0
Austria
Query!
State/province [4]
0
0
Wien
Query!
Country [5]
0
0
Belgium
Query!
State/province [5]
0
0
Gent
Query!
Country [6]
0
0
Belgium
Query!
State/province [6]
0
0
Leuven
Query!
Country [7]
0
0
Belgium
Query!
State/province [7]
0
0
Tielt
Query!
Country [8]
0
0
Belgium
Query!
State/province [8]
0
0
Waregem
Query!
Country [9]
0
0
Brazil
Query!
State/province [9]
0
0
RS
Query!
Country [10]
0
0
Brazil
Query!
State/province [10]
0
0
SP
Query!
Country [11]
0
0
Chile
Query!
State/province [11]
0
0
Vina Del Mar
Query!
Country [12]
0
0
Czech Republic
Query!
State/province [12]
0
0
Brno
Query!
Country [13]
0
0
Czech Republic
Query!
State/province [13]
0
0
Ostrava-Poruba
Query!
Country [14]
0
0
Czech Republic
Query!
State/province [14]
0
0
Ostrava
Query!
Country [15]
0
0
Czech Republic
Query!
State/province [15]
0
0
Pilsen
Query!
Country [16]
0
0
Czech Republic
Query!
State/province [16]
0
0
Prague 4
Query!
Country [17]
0
0
Czech Republic
Query!
State/province [17]
0
0
Zlin
Query!
Country [18]
0
0
Denmark
Query!
State/province [18]
0
0
Copenhagen Nv
Query!
Country [19]
0
0
Denmark
Query!
State/province [19]
0
0
Glostrup
Query!
Country [20]
0
0
Denmark
Query!
State/province [20]
0
0
Hellerup
Query!
Country [21]
0
0
Finland
Query!
State/province [21]
0
0
Hus, Helsinki
Query!
Country [22]
0
0
Finland
Query!
State/province [22]
0
0
Kotka
Query!
Country [23]
0
0
Finland
Query!
State/province [23]
0
0
Kuopio
Query!
Country [24]
0
0
Finland
Query!
State/province [24]
0
0
Lahti
Query!
Country [25]
0
0
Finland
Query!
State/province [25]
0
0
Lappeenranta
Query!
Country [26]
0
0
Finland
Query!
State/province [26]
0
0
Oulu
Query!
Country [27]
0
0
France
Query!
State/province [27]
0
0
Cedex 1
Query!
Country [28]
0
0
France
Query!
State/province [28]
0
0
Cedex 20
Query!
Country [29]
0
0
France
Query!
State/province [29]
0
0
Cedex 3
Query!
Country [30]
0
0
France
Query!
State/province [30]
0
0
Cedex
Query!
Country [31]
0
0
France
Query!
State/province [31]
0
0
Besancon
Query!
Country [32]
0
0
France
Query!
State/province [32]
0
0
Marseille
Query!
Country [33]
0
0
France
Query!
State/province [33]
0
0
Nice
Query!
Country [34]
0
0
France
Query!
State/province [34]
0
0
Paris
Query!
Country [35]
0
0
Germany
Query!
State/province [35]
0
0
Bad Rodach
Query!
Country [36]
0
0
Germany
Query!
State/province [36]
0
0
Berlin
Query!
Country [37]
0
0
Germany
Query!
State/province [37]
0
0
Essen
Query!
Country [38]
0
0
Germany
Query!
State/province [38]
0
0
Heidelberg
Query!
Country [39]
0
0
Germany
Query!
State/province [39]
0
0
Leipzig
Query!
Country [40]
0
0
Germany
Query!
State/province [40]
0
0
Mannheim
Query!
Country [41]
0
0
Germany
Query!
State/province [41]
0
0
Minden
Query!
Country [42]
0
0
Germany
Query!
State/province [42]
0
0
Muenchen
Query!
Country [43]
0
0
Germany
Query!
State/province [43]
0
0
Muenster
Query!
Country [44]
0
0
Germany
Query!
State/province [44]
0
0
Regensburg
Query!
Country [45]
0
0
Greece
Query!
State/province [45]
0
0
Melissia
Query!
Country [46]
0
0
Greece
Query!
State/province [46]
0
0
Athens
Query!
Country [47]
0
0
Greece
Query!
State/province [47]
0
0
Thessaloniki
Query!
Country [48]
0
0
Israel
Query!
State/province [48]
0
0
Haifa
Query!
Country [49]
0
0
Israel
Query!
State/province [49]
0
0
Holon
Query!
Country [50]
0
0
Israel
Query!
State/province [50]
0
0
Petach-tikva
Query!
Country [51]
0
0
Israel
Query!
State/province [51]
0
0
Tel Aviv
Query!
Country [52]
0
0
Italy
Query!
State/province [52]
0
0
Perugia
Query!
Country [53]
0
0
Italy
Query!
State/province [53]
0
0
Bari
Query!
Country [54]
0
0
Italy
Query!
State/province [54]
0
0
Bergamo
Query!
Country [55]
0
0
Italy
Query!
State/province [55]
0
0
Genova
Query!
Country [56]
0
0
Italy
Query!
State/province [56]
0
0
Milano
Query!
Country [57]
0
0
Italy
Query!
State/province [57]
0
0
Monza
Query!
Country [58]
0
0
Mexico
Query!
State/province [58]
0
0
Nuevo Leon
Query!
Country [59]
0
0
Netherlands
Query!
State/province [59]
0
0
GD
Query!
Country [60]
0
0
Netherlands
Query!
State/province [60]
0
0
Almelo
Query!
Country [61]
0
0
Netherlands
Query!
State/province [61]
0
0
Delft
Query!
Country [62]
0
0
Netherlands
Query!
State/province [62]
0
0
Goes
Query!
Country [63]
0
0
Netherlands
Query!
State/province [63]
0
0
RB Groningen
Query!
Country [64]
0
0
Netherlands
Query!
State/province [64]
0
0
Tilburg
Query!
Country [65]
0
0
New Zealand
Query!
State/province [65]
0
0
Auckland
Query!
Country [66]
0
0
New Zealand
Query!
State/province [66]
0
0
Christchurch
Query!
Country [67]
0
0
Poland
Query!
State/province [67]
0
0
Bialystok
Query!
Country [68]
0
0
Poland
Query!
State/province [68]
0
0
Krakow
Query!
Country [69]
0
0
Poland
Query!
State/province [69]
0
0
Lublin
Query!
Country [70]
0
0
Poland
Query!
State/province [70]
0
0
Poznan
Query!
Country [71]
0
0
Poland
Query!
State/province [71]
0
0
Sosnowiec
Query!
Country [72]
0
0
Poland
Query!
State/province [72]
0
0
Warszawa
Query!
Country [73]
0
0
Poland
Query!
State/province [73]
0
0
Wroclaw
Query!
Country [74]
0
0
Portugal
Query!
State/province [74]
0
0
Coimbra Codex
Query!
Country [75]
0
0
Portugal
Query!
State/province [75]
0
0
Lisboa
Query!
Country [76]
0
0
Portugal
Query!
State/province [76]
0
0
Porto
Query!
Country [77]
0
0
Slovakia
Query!
State/province [77]
0
0
Bratislava
Query!
Country [78]
0
0
South Africa
Query!
State/province [78]
0
0
Bloemfontein
Query!
Country [79]
0
0
South Africa
Query!
State/province [79]
0
0
Cape Town
Query!
Country [80]
0
0
South Africa
Query!
State/province [80]
0
0
Parow
Query!
Country [81]
0
0
Spain
Query!
State/province [81]
0
0
Barcelona
Query!
Country [82]
0
0
Spain
Query!
State/province [82]
0
0
Malaga
Query!
Country [83]
0
0
Spain
Query!
State/province [83]
0
0
Alicante
Query!
Country [84]
0
0
Spain
Query!
State/province [84]
0
0
Burgos
Query!
Country [85]
0
0
Spain
Query!
State/province [85]
0
0
Girona
Query!
Country [86]
0
0
Spain
Query!
State/province [86]
0
0
Madrid
Query!
Country [87]
0
0
Spain
Query!
State/province [87]
0
0
Palma de Mallorca
Query!
Country [88]
0
0
Spain
Query!
State/province [88]
0
0
Sevilla
Query!
Country [89]
0
0
Spain
Query!
State/province [89]
0
0
Valencia
Query!
Country [90]
0
0
Spain
Query!
State/province [90]
0
0
Zaragoza
Query!
Country [91]
0
0
Sweden
Query!
State/province [91]
0
0
Danderyd
Query!
Country [92]
0
0
Sweden
Query!
State/province [92]
0
0
Stockholm
Query!
Country [93]
0
0
Sweden
Query!
State/province [93]
0
0
Umea
Query!
Country [94]
0
0
Sweden
Query!
State/province [94]
0
0
Uppsala
Query!
Country [95]
0
0
Sweden
Query!
State/province [95]
0
0
Vaestervik
Query!
Country [96]
0
0
Switzerland
Query!
State/province [96]
0
0
Aarau
Query!
Country [97]
0
0
Switzerland
Query!
State/province [97]
0
0
Basel
Query!
Country [98]
0
0
Switzerland
Query!
State/province [98]
0
0
Bern
Query!
Country [99]
0
0
Switzerland
Query!
State/province [99]
0
0
Lausanne
Query!
Country [100]
0
0
Switzerland
Query!
State/province [100]
0
0
Zurich
Query!
Country [101]
0
0
United Kingdom
Query!
State/province [101]
0
0
Scotland
Query!
Country [102]
0
0
United Kingdom
Query!
State/province [102]
0
0
South Wales
Query!
Country [103]
0
0
United Kingdom
Query!
State/province [103]
0
0
Aberdeen
Query!
Country [104]
0
0
United Kingdom
Query!
State/province [104]
0
0
Cardiff
Query!
Country [105]
0
0
United Kingdom
Query!
State/province [105]
0
0
Glasgow
Query!
Country [106]
0
0
United Kingdom
Query!
State/province [106]
0
0
Liverpool
Query!
Country [107]
0
0
United Kingdom
Query!
State/province [107]
0
0
Nottingham
Query!
Country [108]
0
0
United Kingdom
Query!
State/province [108]
0
0
Woolwich
Query!
Country [109]
0
0
Venezuela
Query!
State/province [109]
0
0
Caracas
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Pfizer
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.
Query!
Trial website
https://clinicaltrials.gov/study/NCT00147602
Query!
Trial related presentations / publications
Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 Aug 10;355(6):549-59. doi: 10.1056/NEJMoa061894. Erratum In: N Engl J Med. 2018 Jun 13;378(25):2450. doi: 10.1056/NEJMx180019. Szarek M, Amarenco P, Callahan A, DeMicco D, Fayyad R, Goldstein LB, Laskey R, Sillesen H, Welch KM; SPARCL Committees and Investigators. Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol. 2020 May 5;75(17):2110-2118. doi: 10.1016/j.jacc.2020.03.015. Epub 2020 Mar 16. Vogt L, Bangalore S, Fayyad R, Melamed S, Hovingh GK, DeMicco DA, Waters DD. Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials. J Am Heart Assoc. 2019 May 7;8(9):e010827. doi: 10.1161/JAHA.118.010827. Ganz P, Amarenco P, Goldstein LB, Sillesen H, Bao W, Preston GM, Welch KMA; SPARCL Steering Committee. Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. Stroke. 2017 Dec;48(12):3223-3231. doi: 10.1161/STROKEAHA.117.017965. Epub 2017 Nov 7. Byun YS, Yang X, Bao W, DeMicco D, Laskey R, Witztum JL, Tsimikas S; SPARCL Trial Investigators. Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack. J Am Coll Cardiol. 2017 Jan 17;69(2):147-158. doi: 10.1016/j.jacc.2016.10.057. Amarenco P, Callahan A 3rd, Campese VM, Goldstein LB, Hennerici MG, Messig M, Sillesen H, Welch KM, Wilson DJ, Zivin JA. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014 Oct;45(10):2974-82. doi: 10.1161/STROKEAHA.114.005832. Epub 2014 Aug 21. Ovbiagele B, Goldstein LB, Amarenco P, Messig M, Sillesen H, Callahan A 3rd, Hennerici MG, Zivin J, Welch KM; SPARCL Investigators. Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr;23(4):778-84. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.001. Epub 2014 Feb 24. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, Hennerici M, Zivin JA, Welch KM; SPARCL Investigators. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011 Oct;68(10):1245-51. doi: 10.1001/archneurol.2011.146. Epub 2011 Jun 13. Schwartz GG, Chaitman BR, Goldberger JJ, Messig M. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Am Heart J. 2011 May;161(5):993-9. doi: 10.1016/j.ahj.2011.02.002. Amarenco P, Goldstein LB, Sillesen H, Benavente O, Zweifler RM, Callahan A 3rd, Hennerici MG, Zivin JA, Welch KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010 Mar;41(3):426-30. doi: 10.1161/STROKEAHA.109.564781. Epub 2010 Jan 28. Amarenco P, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, O'Neill BJ, Rudolph AE, Simunovic L, Zivin JA, Welch KM; SPARCL Investigators. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun;204(2):515-20. doi: 10.1016/j.atherosclerosis.2008.09.008. Epub 2008 Sep 18.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Pfizer CT.gov Call Center
Query!
Address
0
0
Pfizer
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Type
Citations or Other Details
Journal
Amarenco P, Bogousslavsky J, Callahan A 3rd, Golds...
[
More Details
]
Results not provided in
https://clinicaltrials.gov/study/NCT00147602
Download to PDF
Show all queries